Cargando…
New drugs for the treatment of metastatic colorectal cancer
Colorectal cancer (CRC) represents one of the most frequent malignancies in terms of incidence and mortality, thus representing the third leading cause of cancer death worldwide. In the last decade, few drugs have enriched the treatment landscape of metastatic CRC and have significantly affected pro...
Autores principales: | Cherri, Sara, Libertini, Michela, Zaniboni, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603451/ https://www.ncbi.nlm.nih.gov/pubmed/34853636 http://dx.doi.org/10.4251/wjgo.v13.i11.1551 |
Ejemplares similares
-
Optimizing the first-line treatment for metastatic colorectal cancer
por: Cherri, Sara, et al.
Publicado: (2023) -
Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era
por: Cherri, Sara, et al.
Publicado: (2021) -
Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors
por: Cherri, Sara, et al.
Publicado: (2023) -
Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2019) -
Pancreatic adenocarcinoma: Beyond first line, where are we?
por: Cherri, Sara, et al.
Publicado: (2021)